Cargando…

P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

Detalles Bibliográficos
Autores principales:	Kwiatek, Michal, Subramanian Guru Murthy, Guru, Hoffmann, Marc, Roeker, Lindsey, Tessoulin, Benoit, Danilov, Alexey, Alencar, Alvaro J., Shah, Nirav N., Ghesquieres, Herve, Le Gouill, Steven, Jurczak, Wojciech, R. Mato, Anthony, Patel, Vishalkumar, Guo-Avrutin, Yingying, Pauff, James M., Kazmierczak, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429384/ http://dx.doi.org/10.1097/01.HS9.0000969448.21678.5f

Ejemplares similares

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer
por: Kian, Waleed, et al.
Publicado: (2020)

Estudios de pequeña velocidad Op. 636
por: Czerny, Carl, 1791-1857
Publicado: (1994)

Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101
por: Nagasubramanian, Ramamoorthy, et al.
Publicado: (2016)

Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations
por: Ortiz, Michael V., et al.
Publicado: (2020)

Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases
por: Guo, Robin, et al.
Publicado: (2019)

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer
por: Watanabe, Satomi, et al.
Publicado: (2021)

24 Studi della piccola velocita Op. 636 : per pianoforte
por: Czerny, Karl, 1791-1857
Publicado: (1949)

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib
por: Abidi, Maheen Z., et al.
Publicado: (2016)

FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
por: Varma, Madhu, et al.
Publicado: (2023)

Emerging Therapies in Penile Cancer
por: Alencar, Antonio Machado, et al.
Publicado: (2022)

Beam-time for IS 338
por: CERN. Geneva. ISOLDE Experiments Committee
Publicado: (1996)

OP 262-338
Publicado: (2005)

Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies
por: Mohan, Meera, et al.
Publicado: (2022)

636. The Hepcidin-25 and Iron Kinetics During the Acute Phase of Systemic Infection
por: Moro, Hiroshi, et al.
Publicado: (2018)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
por: Andreev-Drakhlin, Alexander, et al.
Publicado: (2020)

SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation
por: Cabanillas, Maria E, et al.
Publicado: (2020)

338 días de Tlatelolco
por: García Robles, Alfonso, 1911-1991
Publicado: (1977)

S338 Medical challenges in migrants
por: Jelinek, T.
Publicado: (2007)

Interleukin-6 (-636 C/G) Gene Polymorphism in Korean Children With Kawasaki Disease
por: Ahn, Hye Mi, et al.
Publicado: (2011)

The Influence of the I7 Experimental Magnets on the Beams, Runs 631, 636, 646, 662
por: Hoffmann, H
Publicado: (1976)

636. Epidemiology and Outcome Among the Elderly Hospitalized Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

Novel-agent combination therapies in chronic lymphocytic leukemia: the law of relative contributions
por: Mato, Anthony R., et al.
Publicado: (2022)

Nutrient Intake in Italian Infants and Toddlers from North and South Italy: The Nutrintake 636 Study
por: Zuccotti, Gian Vincenzo, et al.
Publicado: (2014)

Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir
por: Morishita, Asahiro, et al.
Publicado: (2018)

miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2019)

SAT636 Obesity And Aging Interactions Modify The Breast Tissue Microbiome Influencing Cancer Risk
por: Iyengar, Neil M, et al.
Publicado: (2023)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

Health Tract No. 338: Moral Annoyances
Publicado: (1868)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

Two New Piperazine-Triones from a Marine-Derived Streptomycetes sp. Strain SMS636
por: Xu, Xiuli, et al.
Publicado: (2019)

Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636
por: Song, Jianxiang, et al.
Publicado: (2020)

SAT-636 The Fast-Evolving Connected Diabetes Care Landscape: Transforming Diabetes Care with Telehealth and Technology
por: Levine, Brian, et al.
Publicado: (2020)

Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa
por: Moodley, Jinesa, et al.
Publicado: (2020)

1574P Mortality of 1,636 COVID-19 cancer patients (pts) and associated prognostic factors
por: Ascierto, P.A., et al.
Publicado: (2021)

636. Meningococcal Vaccination and Antibiotic Prophylaxis Practices in Solid Organ Transplant Recipients undergoing Eculizumab Therapy
por: Bhaimia, Eric, et al.
Publicado: (2022)

MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice
por: Li, Junhua, et al.
Publicado: (2020)

Controlling the Smoking Epidemic: Report of the WHO Expert Committee on Smoking Control. WHO Technical Report Series No. 636
por: Alderson, M. R.
Publicado: (1979)

PLD1 regulates adipogenic differentiation through mTOR - IRS-1 phosphorylation at serine 636/639
por: Song, Hae-In, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h1nb1hdcdd6gg0p27uvrb1let4